SMRI: A New Method for SiRNA Design for COVID-19 Therapy
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Supplementary Information: The online version contains supplementary material available at 10.1007/s11390-021-0826-x.
References
1.
Schubert S, Grunweller A, Erdmann V, Kurreck J
. Local RNA target structure influences siRNA efficacy: systematic analysis of intentionally designed binding regions. J Mol Biol. 2005; 348(4):883-93.
DOI: 10.1016/j.jmb.2005.03.011.
View
2.
Vance V, Vaucheret H
. RNA silencing in plants--defense and counterdefense. Science. 2001; 292(5525):2277-80.
DOI: 10.1126/science.1061334.
View
3.
Hsieh A, Bo R, Manola J, Vazquez F, Bare O, Khvorova A
. A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens. Nucleic Acids Res. 2004; 32(3):893-901.
PMC: 373385.
DOI: 10.1093/nar/gkh238.
View
4.
Preall J, Sontheimer E
. RNAi: RISC gets loaded. Cell. 2005; 123(4):543-5.
DOI: 10.1016/j.cell.2005.11.006.
View
5.
Amarzguioui M, Prydz H
. An algorithm for selection of functional siRNA sequences. Biochem Biophys Res Commun. 2004; 316(4):1050-8.
DOI: 10.1016/j.bbrc.2004.02.157.
View